{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T05:08:39Z","timestamp":1784956119885,"version":"3.55.0"},"reference-count":48,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,2,15]],"date-time":"2022-02-15T00:00:00Z","timestamp":1644883200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["esmoopen.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["ESMO Open"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1016\/j.esmoop.2022.100426","type":"journal-article","created":{"date-parts":[[2022,3,22]],"date-time":"2022-03-22T19:25:46Z","timestamp":1647977146000},"page":"100426","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Effect of concomitant statin treatment in postmenopausal patients with hormone receptor-positive early-stage breast cancer receiving adjuvant denosumab or placebo: a post hoc analysis of ABCSG-18"],"prefix":"10.1016","volume":"7","author":[{"given":"C.","family":"Minichsdorfer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Fuereder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Leutner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.F.","family":"Singer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Kacerovsky-Strobl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Egle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Greil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Balic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Fitzal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Pfeiler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Frantal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Bartsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Gnant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.esmoop.2022.100426_bib1","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1016\/j.annonc.2021.06.023","article-title":"Customizing local and systemic therapies for women with early breast cancer: the St. Gallen International Consensus Guidelines for treatment of early breast cancer 2021","volume":"32","author":"Burstein","year":"2021","journal-title":"Ann Oncol"},{"issue":"10001","key":"10.1016\/j.esmoop.2022.100426_bib2","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/S0140-6736(15)61074-1","article-title":"Aromatase inhibitors versus tamoxifen in early breast cancer: patient-level meta-analysis of the randomised trials","volume":"386","year":"2015","journal-title":"Lancet"},{"issue":"26","key":"10.1016\/j.esmoop.2022.100426_bib3","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1056\/NEJMoa052258","article-title":"A\u00a0comparison of letrozole and tamoxifen in postmenopausal women with early breast cancer","volume":"353","author":"Thurlimann","year":"2005","journal-title":"N\u00a0Engl J Med"},{"issue":"9453","key":"10.1016\/j.esmoop.2022.100426_bib4","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/S0140-6736(04)17666-6","article-title":"Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years\u2019 adjuvant treatment for breast cancer","volume":"365","author":"Howell","year":"2005","journal-title":"Lancet"},{"issue":"17","key":"10.1016\/j.esmoop.2022.100426_bib5","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1093\/jnci\/dji250","article-title":"Randomized trial of letrozole following tamoxifen as extended adjuvant therapy in receptor-positive breast cancer: updated findings from NCIC CTG MA.17","volume":"97","author":"Goss","year":"2005","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"2","key":"10.1016\/j.esmoop.2022.100426_bib6","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S1470-2045(07)70003-7","article-title":"Skeletal effects of exemestane on bone-mineral density, bone biomarkers, and fracture incidence in postmenopausal women with early breast cancer participating in the Intergroup Exemestane Study (IES): a randomised controlled study","volume":"8","author":"Coleman","year":"2007","journal-title":"Lancet Oncol"},{"issue":"6257","key":"10.1016\/j.esmoop.2022.100426_bib7","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/343425a0","article-title":"Regulation of the mevalonate pathway","volume":"343","author":"Goldstein","year":"1990","journal-title":"Nature"},{"issue":"10","key":"10.1016\/j.esmoop.2022.100426_bib8","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1093\/carcin\/bgh201","article-title":"Lovastatin inhibits tumor growth and lung metastasis in mouse mammary carcinoma model: a p53-independent mitochondrial-mediated apoptotic mechanism","volume":"25","author":"Shibata","year":"2004","journal-title":"Carcinogenesis"},{"issue":"1","key":"10.1016\/j.esmoop.2022.100426_bib9","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1023\/A:1006058409974","article-title":"Reduction of mouse mammary tumor formation and metastasis by lovastatin, an inhibitor of the mevalonate pathway of cholesterol synthesis","volume":"50","author":"Alonso","year":"1998","journal-title":"Breast Cancer Res Treat"},{"issue":"13","key":"10.1016\/j.esmoop.2022.100426_bib10","doi-asserted-by":"crossref","first-page":"11314","DOI":"10.1074\/jbc.M110.193714","article-title":"Simvastatin prevents skeletal metastasis of breast cancer by an antagonistic interplay between p53 and CD44","volume":"286","author":"Mandal","year":"2011","journal-title":"J\u00a0Biol Chem"},{"issue":"5446","key":"10.1016\/j.esmoop.2022.100426_bib11","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1126\/science.286.5446.1946","article-title":"Stimulation of bone formation in\u00a0vitro and in rodents by statins","volume":"286","author":"Mundy","year":"1999","journal-title":"Science"},{"issue":"8","key":"10.1016\/j.esmoop.2022.100426_bib12","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1002\/ijc.23745","article-title":"Simvastatin, 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, suppresses osteoclastogenesis induced by receptor activator of nuclear factor-kappaB ligand through modulation of NF-kappaB pathway","volume":"123","author":"Ahn","year":"2008","journal-title":"Int J Cancer"},{"issue":"3","key":"10.1016\/j.esmoop.2022.100426_bib13","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1677\/JOE-07-0532","article-title":"Simvastatin antagonizes tumor necrosis factor-alpha inhibition of bone morphogenetic proteins-2-induced osteoblast differentiation by regulating Smad signaling and Ras\/Rho-mitogen-activated protein kinase pathway","volume":"196","author":"Yamashita","year":"2008","journal-title":"J\u00a0Endocrinol"},{"issue":"1-3","key":"10.1016\/j.esmoop.2022.100426_bib14","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.regpep.2010.03.003","article-title":"Simvastatin inhibits osteoclast differentiation induced by bone morphogenetic protein-2 and RANKL through regulating MAPK, AKT and Src signaling","volume":"162","author":"Yamashita","year":"2010","journal-title":"Regul Pept"},{"issue":"2","key":"10.1016\/j.esmoop.2022.100426_bib15","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1097\/00008390-200504000-00001","article-title":"Lovastatin-induced apoptosis in human melanoma cell lines","volume":"15","author":"Shellman","year":"2005","journal-title":"Melanoma Res"},{"issue":"9","key":"10.1016\/j.esmoop.2022.100426_bib16","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1158\/1535-7163.MCT-06-0175","article-title":"Differential efficacy of 3-hydroxy-3-methylglutaryl CoA reductase inhibitors on the cell cycle of prostate cancer cells","volume":"5","author":"Sivaprasad","year":"2006","journal-title":"Mol Cancer Ther"},{"issue":"4","key":"10.1016\/j.esmoop.2022.100426_bib17","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1097\/01.GME.0000055485.06076.00","article-title":"Effect of statins combined with estradiol on the proliferation of human receptor-positive and receptor-negative breast cancer cells","volume":"10","author":"Mueck","year":"2003","journal-title":"Menopause"},{"issue":"1","key":"10.1016\/j.esmoop.2022.100426_bib18","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1055\/s-2003-37501","article-title":"Statins can inhibit proliferation of human breast cancer cells in\u00a0vitro","volume":"111","author":"Seeger","year":"2003","journal-title":"Exp Clin Endocrinol Diabetes"},{"issue":"2","key":"10.1016\/j.esmoop.2022.100426_bib19","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.jocd.2008.02.002","article-title":"Clinical potential of RANKL inhibition for the management of postmenopausal osteoporosis and other metabolic bone diseases","volume":"11","author":"Delmas","year":"2008","journal-title":"J\u00a0Clin Densitom"},{"issue":"3","key":"10.1016\/j.esmoop.2022.100426_bib20","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1038\/pcan.2012.18","article-title":"Responder analysis of the effects of denosumab on bone mineral density in men receiving androgen deprivation therapy for prostate cancer","volume":"15","author":"Egerdie","year":"2012","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"9992","key":"10.1016\/j.esmoop.2022.100426_bib21","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/S0140-6736(15)60995-3","article-title":"Adjuvant denosumab in breast cancer (ABCSG-18): a multicentre, randomised, double-blind, placebo-controlled trial","volume":"386","author":"Gnant","year":"2015","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.esmoop.2022.100426_bib22","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S1470-2045(18)30862-3","article-title":"Adjuvant denosumab in postmenopausal patients with hormone receptor-positive breast cancer (ABCSG-18): disease-free survival results from a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"20","author":"Gnant","year":"2019","journal-title":"Lancet Oncol"},{"issue":"4","key":"10.1016\/j.esmoop.2022.100426_bib23","doi-asserted-by":"crossref","first-page":"R187","DOI":"10.1186\/ar4018","article-title":"Atorvastatin inhibits osteoclastogenesis by decreasing the expression of RANKL in the synoviocytes of rheumatoid arthritis","volume":"14","author":"Kim","year":"2012","journal-title":"Arthritis Res Ther"},{"issue":"2","key":"10.1016\/j.esmoop.2022.100426_bib24","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.canlet.2012.10.003","article-title":"Eliminating drug resistant breast cancer stem-like cells with combination of simvastatin and gamma-tocotrienol","volume":"328","author":"Gopalan","year":"2013","journal-title":"Cancer Lett"},{"issue":"1","key":"10.1016\/j.esmoop.2022.100426_bib25","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.canlet.2012.08.031","article-title":"Simvastatin inhibition of mevalonate pathway induces apoptosis in human breast cancer cells via activation of JNK\/CHOP\/DR5 signaling pathway","volume":"329","author":"Gopalan","year":"2013","journal-title":"Cancer Lett"},{"issue":"12","key":"10.1016\/j.esmoop.2022.100426_bib26","doi-asserted-by":"crossref","first-page":"695","DOI":"10.5414\/CPP42695","article-title":"Inhibitory effect of statins on the proliferation of human breast cancer cells","volume":"42","author":"Muck","year":"2004","journal-title":"Int J Clin Pharmacol Ther"},{"issue":"19","key":"10.1016\/j.esmoop.2022.100426_bib27","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1093\/jnci\/djr291","article-title":"Statin prescriptions and breast cancer recurrence risk: a Danish nationwide prospective cohort study","volume":"103","author":"Ahern","year":"2011","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"3","key":"10.1016\/j.esmoop.2022.100426_bib28","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1007\/s10549-007-9683-8","article-title":"Post-diagnosis statin use and breast cancer recurrence in a prospective cohort study of early stage breast cancer survivors","volume":"109","author":"Kwan","year":"2008","journal-title":"Breast Cancer Res Treat"},{"issue":"6","key":"10.1016\/j.esmoop.2022.100426_bib29","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1002\/ijc.30185","article-title":"Impact of statin use on cancer recurrence and mortality in breast cancer: a systematic review and meta-analysis","volume":"139","author":"Manthravadi","year":"2016","journal-title":"Int J Cancer"},{"issue":"1","key":"10.1016\/j.esmoop.2022.100426_bib30","doi-asserted-by":"crossref","first-page":"72","DOI":"10.18433\/J3202B","article-title":"Statins use and risk of breast cancer recurrence and death: a systematic review and meta-analysis of observational studies","volume":"19","author":"Mansourian","year":"2016","journal-title":"J\u00a0Pharm Pharm Sci"},{"issue":"5","key":"10.1016\/j.esmoop.2022.100426_bib31","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1158\/1055-9965.EPI-07-0726","article-title":"Estrogen receptor-negative breast cancer is less likely to arise among lipophilic statin users","volume":"17","author":"Kumar","year":"2008","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"10","key":"10.1016\/j.esmoop.2022.100426_bib32","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.1158\/1055-9965.EPI-10-0524","article-title":"Lipophilic statin use and risk of breast cancer subtypes","volume":"19","author":"Woditschka","year":"2010","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"10","key":"10.1016\/j.esmoop.2022.100426_bib33","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1158\/1055-9965.EPI-13-0562","article-title":"Prospective analysis of association between statin use and breast cancer risk in the women\u2019s health initiative","volume":"22","author":"Desai","year":"2013","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"4","key":"10.1016\/j.esmoop.2022.100426_bib34","first-page":"529","article-title":"Statins and breast cancer stage and mortality in the Women\u2019s Health Initiative","volume":"26","author":"Desai","year":"2015","journal-title":"Cancer Causes Control"},{"issue":"5","key":"10.1016\/j.esmoop.2022.100426_bib35","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1002\/ijc.23597","article-title":"HMG-CoA reductase expression in breast cancer is associated with a less aggressive phenotype and influenced by anthropometric factors","volume":"123","author":"Borgquist","year":"2008","journal-title":"Int J Cancer"},{"issue":"5","key":"10.1016\/j.esmoop.2022.100426_bib36","doi-asserted-by":"crossref","first-page":"R79","DOI":"10.1186\/bcr2146","article-title":"Prognostic impact of tumour-specific HMG-CoA reductase expression in primary breast cancer","volume":"10","author":"Borgquist","year":"2008","journal-title":"Breast Cancer Res"},{"issue":"26","key":"10.1016\/j.esmoop.2022.100426_bib37","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000011220","article-title":"Body mass index and prognosis of breast cancer: an analysis by menstruation status when breast cancer diagnosis","volume":"97","author":"Sun","year":"2018","journal-title":"Medicine (Baltimore)"},{"issue":"49","key":"10.1016\/j.esmoop.2022.100426_bib38","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000005602","article-title":"Diabetes mellitus and prognosis in women with breast cancer: a systematic review and meta-analysis","volume":"95","author":"Zhao","year":"2016","journal-title":"Medicine (Baltimore)"},{"issue":"12","key":"10.1016\/j.esmoop.2022.100426_bib39","doi-asserted-by":"crossref","first-page":"3011","DOI":"10.1093\/annonc\/mdt367","article-title":"Diabetes in relation to breast cancer relapse and all-cause mortality in elderly breast cancer patients: a FOCUS study analysis","volume":"24","author":"Kiderlen","year":"2013","journal-title":"Ann Oncol"},{"issue":"1","key":"10.1016\/j.esmoop.2022.100426_bib40","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1186\/s12885-021-08716-5","article-title":"Cardiovascular disease in women with breast cancer - a nationwide cohort study","volume":"21","author":"Jakobsen","year":"2021","journal-title":"BMC Cancer"},{"issue":"1","key":"10.1016\/j.esmoop.2022.100426_bib41","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s00198-016-3844-8","article-title":"Efficacy of statins for osteoporosis: a systematic review and meta-analysis","volume":"28","author":"An","year":"2017","journal-title":"Osteoporos Int"},{"issue":"12","key":"10.1016\/j.esmoop.2022.100426_bib42","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1136\/annrheumdis-2019-215714","article-title":"Diagnosis of osteoporosis in statin-treated patients is dose-dependent","volume":"78","author":"Leutner","year":"2019","journal-title":"Ann Rheum Dis"},{"issue":"41","key":"10.1016\/j.esmoop.2022.100426_bib43","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000017476","article-title":"Case-control study examining the association between hip fracture risk and statins therapy in old people","volume":"98","author":"Cheng","year":"2019","journal-title":"Medicine (Baltimore)"},{"issue":"9","key":"10.1016\/j.esmoop.2022.100426_bib44","doi-asserted-by":"crossref","first-page":"3439","DOI":"10.1210\/jc.2018-00652","article-title":"Statin use is associated with decreased osteoporosis and fracture risks in stroke patients","volume":"103","author":"Lin","year":"2018","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.esmoop.2022.100426_bib45","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0196713","article-title":"Long-term effect of statins on the risk of new-onset osteoporosis: a nationwide population-based cohort study","volume":"13","author":"Lin","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.esmoop.2022.100426_bib46","doi-asserted-by":"crossref","first-page":"159","DOI":"10.2147\/CLEP.S145311","article-title":"High-potency statins but not all statins decrease the risk of new-onset osteoporotic fractures: a nationwide population-based longitudinal cohort study","volume":"10","author":"Lin","year":"2018","journal-title":"Clin Epidemiol"},{"issue":"2","key":"10.1016\/j.esmoop.2022.100426_bib47","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1001\/jamainternmed.2014.6388","article-title":"Statin therapy and risk of fracture: results from the JUPITER randomized clinical trial","volume":"175","author":"Pena","year":"2015","journal-title":"JAMA Intern Med"},{"issue":"14","key":"10.1016\/j.esmoop.2022.100426_bib48","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1001\/jama.285.14.1850","article-title":"Use of statins and risk of fractures","volume":"285","author":"van Staa","year":"2001","journal-title":"JAMA"}],"container-title":["ESMO Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2059702922000473?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2059702922000473?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T20:25:17Z","timestamp":1761855917000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2059702922000473"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":48,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["S2059702922000473"],"URL":"https:\/\/doi.org\/10.1016\/j.esmoop.2022.100426","relation":{},"ISSN":["2059-7029"],"issn-type":[{"value":"2059-7029","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of concomitant statin treatment in postmenopausal patients with hormone receptor-positive early-stage breast cancer receiving adjuvant denosumab or placebo: a post hoc analysis of ABCSG-18","name":"articletitle","label":"Article Title"},{"value":"ESMO Open","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.esmoop.2022.100426","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Ltd on behalf of European Society for Medical Oncology.","name":"copyright","label":"Copyright"}],"article-number":"100426"}}